Advocacy

Pharmacist Groups Call on Biden Administration to Remove Limits on Prescribing COVID Treatments

Published: March 9, 2022
ASHP News

Modification to EUAs for Oral Antivirals Needed to Achieve Potential of “Test to Treat” Initiative

Today, 14 pharmacy organizations urged the Biden administration to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative announced last week during the State of the Union.

In a letter sent to President Biden, the groups called for the removal of a limitation placed on the emergency use authorization (EUA) of COVID-19 antivirals by the Food and Drug Administration (FDA). The limitation prevents pharmacists from ordering the medications. The groups stressed that limitations in the EUAs for COVID-19 oral antivirals mean that patients in rural and underserved communities will be less likely to benefit from the test to treat approach.

“Despite your statement during the State of the Union, Americans who test positive at a pharmacy will only be able to access time-sensitive oral antivirals, on the spot, from a limited number of pharmacies with in-house access to non-pharmacist prescribers, primarily in metropolitan areas,” the groups noted.

Many states license pharmacists to order medications, either independently or in collaboration with a physician. In September, the Department of Health and Human Services authorized pharmacists in all 50 states to order oral treatments for COVID-19. The EUAs issued in December by the FDA specifically prevent pharmacists from ordering oral antivirals.

Pharmacists are clinically trained medication experts and are the primary healthcare professionals responsible for ensuring safe medication use, including identifying and mitigating drug interactions associated with oral antiviral medications for COVID-19.

ADVERTISEMENT

Signatories

American Society of Health-System Pharmacists (ASHP)

Academy of Managed Care Pharmacy (AMCP)

American Association of Colleges of Pharmacy (AACP)

American College of Apothecaries (ACA)

American College of Clinical Pharmacy (ACCP)

American Pharmacists Association (APhA)

American Society of Consultant Pharmacists (ASCP)

College of Psychiatric and Neurologic Pharmacists (CPNP)

Hematology/Oncology Pharmacy Association (HOPA)

National Alliance of State Pharmacy Associations (NASPA)

National Association of Boards of Pharmacy (NABP)

National Community Pharmacists Association (NCPA)

National Pharmaceutical Association (NPhA)

Society of Infectious Diseases Pharmacists (SIDP)

 

Posted March 9, 2022

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information